Are CGM For Type 2 Diabetes: A Clear Answer!
Are CGM For Type 2 Diabetes? The Short Answer
Many people with type 2 diabetes (T2D) ask: are cgm for type 2 diabetes? The short answer is yes — CGM is used by people with type 2 diabetes, but NHS access depends on the individual's treatment plan and clinical needs.
Diabetes UK notes that "generally, people with type 1 diabetes should be offered a CGM and some people with type 2 diabetes may also be offered a CGM to help manage diabetes" [1].
The UK cgm suppliers market offers CGM options for a range of user profiles. Whether a T2D patient uses insulin or manages their condition with oral medication alone, CGM may provide valuable continuous glucose trend support.
CGM sensors work by detecting glucose concentration in the subcutaneous interstitial fluid, converting this via an algorithm to an estimated glucose value, with a short physiological delay compared to actual blood glucose.
Do Type 2 Diabetics Get CGMs On The NHS?
The question do type 2 diabetics get cgms on the NHS is closely linked to NHS funding criteria. In England, adults with T2D who use insulin twice daily or more may qualify for an NHS-funded CGM if they meet specific clinical criteria [2].
Qualifying conditions include recurrent or severe hypoglycaemia, impaired hypoglycaemia awareness, or an inability to self-monitor via finger-prick testing but the capacity to use a scanning device.
A requirement for eight or more daily finger-prick tests also qualifies.
Adults with insulin-treated T2D whose blood glucose is monitored by a care worker or healthcare professional are also recommended for CGM under NHS guidance. For full eligibility details, refer to Diabetes UK's official guidance.
Those who do not qualify for NHS funding can self-fund CGM, with typical monthly costs of approximately £50 to £150. Some patients may also apply for an Individual Funding Request through their diabetes care team.
Can Type 2 Diabetics Use A CGM Without Insulin?
Can type 2 diabetics use a cgm without insulin? Yes. While NHS funding is currently focused on insulin-using T2D patients, CGM remains a practical option for those not using insulin.
The ADA 2026 Standards of Care note that evidence supporting CGM benefits for people with type 2 diabetes not using insulin is increasing, with benefits generally greater than those seen with traditional blood glucose monitoring (BGM) [3].
A meta-analysis of six randomised controlled trials covering 407 noninsulin-treated T2D patients found that CGM significantly reduced HbA1c (WMD -0.31%) and increased time in range (TIR, WMD 8.63%) [4].
Although self-funding CGM carries an ongoing cost, the continuous glucose trend data it provides can help non-insulin T2D patients better understand how diet and activity affect their glucose.
Whether CGM is appropriate for your situation is best discussed with your healthcare team.
Is A CGM Worth It For Type 2 Diabetes?
Is a cgm worth it for type 2 diabetes? For most people with T2D, the clinical evidence suggests a meaningful benefit.
One systematic review found that both real-time CGM and intermittently scanned CGM reduced HbA1c by an average of 0.31% and improved TIR by 6.36% in adults with T2D [5].
This exceeded the 5% minimal clinically relevant difference identified by expert consensus in the same review.
Beyond glycaemic metrics, access to quality cgm supplies and their real-time trend data helps patients observe how meals, activity, and medication affect their glucose, supporting sustained behaviour change.
Whether CGM is worth the cost depends on individual clinical needs, current treatment plan, and financial circumstances. A discussion with your diabetes care team can help assess whether CGM aligns with your management goals.
What CGM Devices Are Available For Type 2 Diabetes In The UK?
The table below provides an overview of the main CGM devices currently available in the UK market. For detailed specifications and usage instructions, always refer to each brand's official documentation.
| Brand / Device | Wear Duration | Notes |
|---|---|---|
| Abbott FreeStyle Libre 3 Plus | 15 days (per Abbott official documentation) | Available on NHS prescription in the UK; replacing FreeStyle Libre 3 (14-day sensor) |
| Dexcom G7 | 10 days + 12-hour grace period (per Dexcom official documentation) | Available on NHS prescription in the UK |
| Dexcom ONE+ | 10 days (per Dexcom official documentation) | UK market |
| SIBIONICS GS3 | 14 days (per official user guide) | CE-certified, European market |
SIBIONICS offers the SIBIONICS GS3, a CE-certified medical-grade CGM available in the European market and suitable for people aged 3 and above with Type 1 or Type 2 diabetes.
When selecting a device, consult your diabetes specialist team to confirm NHS prescription eligibility, individual suitability, and usage requirements. Specifications vary between brands and should not be applied interchangeably.
How Does A CGM Work For Type 2 Diabetes Management?
A CGM device uses a small sensor inserted under the skin to continuously measure glucose concentration in the interstitial fluid. Research shows that the physiological delay of glucose transport from the vascular to the interstitial space is approximately 5 to 6 minutes [6].
This means CGM readings reflect glucose trends from a short time earlier rather than an instantaneous precise value. When blood glucose is changing rapidly, CGM readings may differ from a simultaneous finger-prick result.
For people with type 2 diabetes, the key value of CGM lies in providing a continuous glucose trend graph, real-time readings, and trend arrows that help patients understand how meals, activity, sleep, and medication affect their glucose patterns over time.
According to the ADA 2026 Standards of Care, RCT data for insulin-using people with T2D consistently show reductions in HbA1c and increases in TIR, with some improvements attributed to behaviour change rather than insulin dose adjustments alone.
CGM data can be shared with the clinical team to support more precise treatment decisions.
What Are The Limitations Of CGM For Type 2 Diabetes?
Despite the clear benefits of CGM for T2D, several limitations deserve consideration.
First, NHS funding is currently focused on insulin-using T2D patients. Those not using insulin will typically need to self-fund, at an estimated monthly cost of around £50 to £150.
Second, sensor adhesion failure and skin sensitivity are issues reported by some users. Different cgm brands use different adhesive designs and offer varying accessories — always refer to the specific device's user manual for guidance on managing these issues.
Finally, CGM readings are estimated values subject to a physiological lag and cannot directly replace laboratory HbA1c testing. Any significant clinical decisions based on CGM data should be confirmed with a healthcare professional.
Verdict
Overall, CGM is appropriate for people with type 2 diabetes, and the evidence base continues to grow. In the UK, NHS funding is currently focused on insulin-using T2D patients.
For those not using insulin, self-funded CGM use is supported by clinical evidence showing improved glycaemic control.
Device selection should account for NHS prescription eligibility, treatment plan, personal usage needs, and cost.
For more information on SIBIONICS CGM products suitable for people with type 2 diabetes, consult your diabetes care team or visit the official website.
All decisions regarding CGM indications, usage restrictions, and medical management should be made in consultation with a healthcare professional.
FAQ
Q: Are CGM For Type 2 Diabetes?
Yes, CGM is used by people with type 2 diabetes. In the UK, T2D patients who use insulin may qualify for NHS funding. Those not using insulin can self-fund with clinical evidence supporting the benefit.
Specific eligibility should always be confirmed with your healthcare team.
Q: Do Type 2 Diabetics Get CGMs On The NHS?
In England, adults with T2D using insulin twice daily or more may qualify for NHS-funded CGM if they meet specific clinical criteria, such as recurrent hypoglycaemia or an inability to self-monitor via finger-prick tests.
Those who do not qualify can self-fund or apply for an Individual Funding Request through their diabetes team.
Q: Can Type 2 Diabetics Use A CGM Without Insulin?
Yes. Research shows CGM can help improve glycaemic control in T2D patients not using insulin, including reductions in HbA1c and improvements in TIR. Patients can self-fund CGM use and should discuss suitability with their healthcare team.
Q: Is A CGM Worth It For Type 2 Diabetes?
For most T2D patients, CGM can deliver HbA1c improvement (approximately 0.31% reduction), TIR gains, and support for behaviour change.
Whether it is worth the investment depends on individual clinical needs, treatment plan, and cost — discuss this with your diabetes care team.
Q: Which CGM Devices Are Available For Type 2 Diabetes In The UK?
The main CGM devices in the UK include Abbott FreeStyle Libre 3, Dexcom G7, and Dexcom ONE+, all available on NHS prescription when eligibility criteria are met.
SIBIONICS GS3 is a CE-certified medical-grade CGM available in the European market for people aged 3 and above with Type 1 or Type 2 diabetes.
Specifications vary by brand — always refer to official documentation and consult your healthcare team.
References
[1] Diabetes UK. Continuous glucose monitors. diabetes.org.uk. https://www.diabetes.org.uk/about-diabetes/looking-after-diabetes/technology/continuous-glucose-monitors
[2] Diabetes UK. Can I get continuous glucose monitoring on the NHS? diabetes.org.uk. https://www.diabetes.org.uk/about-diabetes/looking-after-diabetes/technology/continuous-glucose-monitors/can-i-get-cgm-on-the-nhs
[3] American Diabetes Association Professional Practice Committee. (2026). Standards of Care in Diabetes—2026. Diabetes Care. https://pmc.ncbi.nlm.nih.gov/articles/PMC12690173/
[4] Ferreira ROM, et al. (2024). Continuous Glucose Monitoring Systems in Noninsulin-Treated People with Type 2 Diabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Diabetes Technology & Therapeutics, 26(4). https://pubmed.ncbi.nlm.nih.gov/38090767/
[5] Hou C, et al. (2024). Continuous glucose monitoring in adults with type 2 diabetes: a systematic review and meta-analysis. pmc.ncbi.nlm.nih.gov. https://pmc.ncbi.nlm.nih.gov/articles/PMC10954850/
[6] Rebrin K, et al. (2013). Time Lag of Glucose From Intravascular to Interstitial Compartment in Humans. pmc.ncbi.nlm.nih.gov. https://pmc.ncbi.nlm.nih.gov/articles/PMC3837059/
Disclaimer
This article is for educational purposes only and does not replace professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.
Author Information
This article was written by the SIBIONICS Professional Health Content Team. The author has years of research experience in CGM and diabetes management, helping users optimize their device experience through science-based practices.
Last Updated: May 09, 2026
Related Reading:
1.How To Get CGM: Insurance, OTC, And Cost Explained!
2.Will Insurance Cover CGM For PCOS: What To Know?
3.How To Check Blood Sugar At Home Naturally: 3 Methods!
